Goodwill and Impairment - The goodwill from the acquisition of 90% of Nosber Cosmetics Co., Ltd. amounted to CNY 1.366 billion, with an impairment provision of CNY 913 million recorded in 2021, and an additional impairment of CNY 453 million in 2022 due to underperformance[1] - A goodwill impairment provision of 452.70 million yuan was required for Norsebel as of September 2022, reflecting the need for adjustments based on the revised earnings outlook[51] - The discount rate for Norsebel's goodwill asset group increased due to significant losses in 2022, raising the specific risk parameter from 1% to 3%[50] - The company has conducted timely goodwill impairment tests, with the latest assessment indicating clear signs of impairment as of Q3 2022[60] Revenue and Sales Performance - The total revenue for Nosber in the first three quarters of 2022 was CNY 965.94 million, a decline from CNY 1.612 billion in 2021, reflecting a decrease of approximately 40%[7] - The sales revenue from the facial mask series in the first three quarters of 2022 was CNY 383.97 million, accounting for 39.76% of total revenue, down from 49.88% in 2019[7] - The wet wipes series saw a revenue drop from CNY 574.12 million in 2020 to CNY 225.10 million in the first three quarters of 2022, reflecting a significant decline in export orders[7] - In the first three quarters of 2022, the company's revenue was CNY 145,469.72 million, a decrease of 18.33% compared to CNY 178,115.07 million in the same period last year[13] - The company's revenue for 2023 is projected to be RMB 249,438 million, representing a growth of 17.5% from 2022[56] Profitability and Margins - The operating profit for the same period was CNY -15,284.51 million, down from CNY 1,678.08 million, representing a decline of CNY 16,962.59 million[13] - The gross profit margin fell to 3.90%, down 8.74% from 12.64% in the previous year[13] - The net profit for the first three quarters was CNY -13,201.69 million, a decrease of CNY 14,335.96 million compared to a net profit of CNY 1,134.27 million in the same period last year[13] - The gross margin for the skincare series dropped from 24.14% in 2019 to 1.98% in 2022, indicating rising costs and changing product mix[9] - The gross profit margin is expected to increase to 12.65% in 2023, up from 10.01% in 2022[56] Cost and Expense Management - The company faced increased costs due to capacity expansion, rising labor costs, and material price hikes, contributing to the overall decline in gross margins across product lines[10] - The company reported a significant increase in material costs due to rising prices of raw materials, impacting profit margins[14] - Interest expenses increased to CNY 2,085.40 million, up CNY 1,202.61 million year-on-year, primarily due to increased borrowing for expansion[15] - Total expenses for 2023 are projected at RMB 4,660.47 million, representing 2.20% of the operating revenue[30] Market Conditions and Industry Trends - The overall market conditions, including commodity price fluctuations and ongoing pandemic effects, have hindered the expected performance from newly added capacities since the second half of 2020[8] - The company is facing challenges due to industry pressures, including regulatory changes and macroeconomic factors, leading to a decline in order volume[14] - Competitors in the industry, such as Jiahen Jiahua and Anter Co., have also reported significant declines in operating and net profits, indicating a broader industry trend[19] - In the first nine months of 2022, the cosmetics industry faced a decline in revenue due to strict pandemic control measures, resulting in a significant drop in demand[46] Future Projections and Financial Outlook - The projected operating revenue for Q4 2022 is RMB 46,466.69 million, with a growth rate of 10.57% for 2023[27] - The estimated operating profit before tax for 2023 is RMB -4,657.65 million, improving to RMB 3,156.10 million in 2024[27] - The forecasted free cash flow for 2026 is RMB 30,931.29 million, with a perpetual growth rate of 0%[27] - The company's operating revenue is expected to recover steadily, reaching RMB 315,532.10 million by 2026, with a projected EBIT margin improving from -5.80% in Q4 2022 to 6.94% in 2026[32] - The company anticipates continued losses in the short term, with expectations of profitability only after significant declines from historical levels[42] Research and Development - Research and development expenses are projected to total RMB 9,465.96 million by 2026, with a steady decrease in the percentage of revenue from 7.03% in Q4 2022 to 4.32% in 2026[31] - The company plans to maintain a stable R&D expense ratio, ensuring compliance with high-tech enterprise certification standards[32] Financial Metrics and Ratios - The average debt-to-equity ratio of comparable companies is 22.17%, which will inform the company's target capital structure moving forward[37] - The market risk premium is calculated at 7.19%, with the market return at 9.95% and the risk-free rate at 2.76%[38] - The weighted average cost of capital (WACC) is determined to be 10.54% (after tax) and 12.23% (before tax)[39]

Financial Performance - The company's revenue for Q3 2022 was ¥726,235,172.74, a decrease of 3.71% compared to the same period last year, and a year-to-date revenue of ¥2,142,303,223.85, down 19.61% year-on-year [4]. - The net profit attributable to shareholders for Q3 2022 was -¥498,561,000.02, a decline of 704.35%, with a year-to-date net profit of -¥657,077,350.85, down 653.82% compared to the previous year [4]. - Total operating revenue for Q3 2022 was ¥2,142,303,223.85, a decrease of 19.5% compared to ¥2,664,857,342.42 in the same period last year [32]. - The net profit attributable to shareholders of the parent company was a loss of ¥657,077,350.85, compared to a profit of ¥118,644,075.28 in Q3 2021 [33]. - The total comprehensive income for Q3 2022 was a loss of ¥653,480,726.70, compared to a profit of ¥118,082,263.99 in Q3 2021 [33]. - Basic and diluted earnings per share were both -¥1.2720, compared to ¥0.2297 in the same period last year [33]. Assets and Liabilities - The company's total assets decreased by 18.97% from the end of the previous year to ¥3,719,974,274.32 [6]. - The equity attributable to shareholders decreased by 31.30% to ¥1,467,095,585.10 compared to the end of the previous year [6]. - The total current assets decreased from 2.63 billion yuan at the beginning of the year to 2.32 billion yuan by September 30, 2022, reflecting a decline of approximately 11.8% [29]. - The total liabilities decreased from 2.46 billion yuan at the beginning of the year to 2.25 billion yuan, indicating a reduction of about 8.5% [30]. - The non-current assets decreased from 1.96 billion yuan to 1.40 billion yuan, reflecting a reduction of approximately 28.5% [30]. - The company's total assets decreased from 4.59 billion yuan to 3.72 billion yuan, a decline of about 19% [30]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥264,277,354.20, an increase of 321.38% compared to the previous year [4]. - Operating cash flow net amount for the first nine months of 2022 was ¥264,277,354.20, a substantial increase of 321.38% from the same period last year, mainly due to reduced payments for material procurement and employee compensation [16]. - The net cash flow from investment activities increased to ¥52,085,724.07, a rise of 137.45%, attributed to decreased expenditures on fixed and intangible assets [16]. - The net cash flow from financing activities decreased to -¥178,282,535.63, a decline of 166.64%, primarily due to reduced borrowing and increased guarantee payments [16]. - The company reported a significant increase in cash and cash equivalents, reaching ¥160,373,673.97, up 1,921.76% compared to the previous year, mainly due to reduced expenditures on operating activities and asset construction [16]. - Cash and cash equivalents at the end of the period increased to ¥731,793,498.34, up from ¥522,555,180.85 at the end of Q3 2021 [38]. Expenses and Impairments - The company recorded a substantial increase in credit impairment losses, amounting to -¥6,250,672.98, reflecting a 32,965.38% change due to provisions for bad debts [14]. - The company reported an asset impairment loss of ¥505,812,456.50, a significant increase of 30,853.35% compared to the previous period, primarily due to goodwill and equipment impairment [15]. - The income tax expense for the period was -¥46,366,300.36, a decrease of 285.95% year-on-year, primarily due to a reduction in total profit [15]. - The company experienced a significant increase in financial expenses, with interest expenses rising to ¥48,396,215.49 from ¥29,361,395.86 in the previous year [32]. - Research and development expenses were ¥91,259,333.62, slightly up from ¥90,192,385.71 in the same period last year [32]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,589, with the top ten shareholders holding significant stakes [18]. - The largest shareholder, Norsbel (Hong Kong) Nonwoven Products Co., Ltd., held 9.17% of the shares, amounting to 47,392,045 shares [18]. Strategic Changes - The company plans to divest 100% equity of two subsidiaries to focus on the cosmetics and consumer goods sectors, with two interested parties having submitted their intent to acquire [24]. - The company intends to issue A-shares to a specific individual, which will result in a change of control, as the individual will become the controlling shareholder [25]. Other Financial Metrics - The company experienced a foreign exchange gain of ¥22,293,131.33, a remarkable increase of 2,010.01%, mainly due to fluctuations in the RMB to USD exchange rate [16]. - The investment income increased significantly by 591.40% to ¥288,816.55, attributed to returns from bank financial products [14]. - The company received operating income of ¥571,209.30, an increase of 109.45% from the previous period, mainly due to compensation received during the current period [15]. - The company reported a significant increase in deferred tax assets by 155.40% to ¥76,795,099.40, mainly due to increased unamortized losses and impairment provisions [12].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,416,068,051.11, a decrease of 25.89% compared to ¥1,910,672,940.84 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was -¥158,516,350.83, representing a decline of 187.76% from ¥180,627,074.82 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was -¥161,866,961.09, down 191.12% from ¥177,642,817.49 in the same period last year[21]. - The net cash flow from operating activities was ¥76,802,994.95, a decrease of 12.97% compared to ¥88,246,943.97 in the previous year[21]. - The total assets at the end of the reporting period were ¥4,330,771,778.57, down 5.66% from ¥4,590,769,337.03 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company were ¥1,965,561,687.05, a decrease of 7.96% from ¥2,135,452,390.48 at the end of the previous year[21]. - The basic earnings per share were -¥0.3069, compared to ¥0.3497 in the same period last year, reflecting a decline of 187.76%[21]. - The diluted earnings per share were also -¥0.3069, down 187.76% from ¥0.3497 in the previous year[21]. - The weighted average return on equity was -7.73%, a decrease of 13.36% from 5.63% in the same period last year[21]. - The company achieved operating revenue of 1,416.07 million yuan, a year-on-year decrease of 25.89%[86]. - The net profit attributable to shareholders was -158.52 million yuan, a year-on-year decrease of 187.76%[86]. - The cosmetics subsidiary, Norsbel, reported operating revenue of 957.05 million yuan, down 23.74% year-on-year[87]. - The gross profit margin for Norsbel was 2.58%, a decrease of 14.48 percentage points year-on-year[87]. - The pine oil deep processing business generated operating revenue of 453.79 million yuan, a year-on-year decline of 30.80%[90]. - The gross profit margin for the pine oil deep processing business was 9.12%, down 21.08 percentage points year-on-year[91]. Market Trends and Challenges - The domestic cosmetics market has grown from 204.9 billion RMB in 2015 to 402.6 billion RMB in 2021, with a compound annual growth rate (CAGR) of 11.92%[31]. - In the first half of 2022, the total retail sales of cosmetics in China amounted to 190.5 billion RMB, a year-on-year decline of 2.5%[31]. - The per capita consumption of cosmetics in China was 62.9 USD in 2021, significantly lower than the 260-300 USD in the US, UK, Japan, and South Korea, indicating substantial growth potential[34]. - The cosmetics industry in China is expected to grow at a CAGR of 7.8% from 2022 to 2026, with the market size projected to reach 844.3 billion RMB by 2026[34]. - The implementation of new regulations in the cosmetics industry is expected to increase entry barriers, benefiting companies with stronger R&D and cost control capabilities[36]. - The overall economic recovery in China has been slow, affecting consumer spending and leading to a decline in retail sales of consumer goods[31]. - The cosmetics industry is experiencing intensified competition with the rise of domestic brands and e-commerce, alongside the expansion of international brands into the Chinese market[30]. - The company faces challenges from rising prices of raw materials and packaging due to PPI increases and supply chain adjustments, impacting production and sales[41]. - The company is facing increased competition in both the cosmetics and turpentine deep processing sectors, which could adversely affect market share and sales revenue[137]. Research and Development - The company is committed to continuous innovation and R&D to develop high-quality products that are competitive in the market[54]. - The company reported a significant focus on R&D for new technologies and products, enhancing its competitive edge in the skincare and hygiene markets[62]. - The company has developed over 770 new and stable formulas during the reporting period, with more than 250 formula registrations completed[98]. - Northbell's R&D team consists of over 230 professionals, focusing on innovative product development across various categories, including skincare and masks[96]. - The company has launched multiple new product lines, including a series of nano quick-dissolving essence masks and a premium water lotion series, responding to market trends[97]. - Northbell has obtained 129 patents, including 30 invention patents, enhancing its competitive edge through differentiated product offerings[98]. - The company has established advanced R&D centers and international standard production bases to provide professional cosmetic production services to numerous brands[48]. Production and Operations - The company has expanded its product range to include various hygiene and cleaning products, such as Clinell gamma disinfectant wipes and baby wipes, targeting diverse market segments[59]. - Norsbel's product categories include facial masks, skincare products, wet wipes, and non-woven fabric products, with facial masks being a significant revenue contributor[48][49]. - Norsbel has established a new production line for nano electrospun masks during the reporting period[84]. - Norsbel's production strategy is centered on self-production, supplemented by outsourcing for specific processes like mask fabric printing and sterilization, allowing for high-quality product output[71]. - Northbell operates 55 automatic mask filling and packaging production lines, demonstrating strong manufacturing capabilities to meet large-scale orders[101]. - The company has a diverse customer base, including international brands like Unilever and Procter & Gamble, which supports sustainable growth through reliable orders[93]. Environmental Compliance - The company reported a total wastewater discharge of 2.408 tons, with a chemical oxygen demand concentration of 44.39 mg/L, adhering to the GB8978-1996 Level 4 standard[152]. - The company achieved a total sulfur dioxide emission of 28.15 tons, with a concentration of 98.98 mg/m³ from the flue gas treatment system[152]. - The nitrogen oxides emissions totaled 68.65 tons, with a concentration of 241.33 mg/m³, complying with the GB13271-2014 standard[152]. - The company’s particulate matter emissions were recorded at 4.49 tons, with a concentration of 15.79 mg/m³ from a 60-meter high chimney[152]. - The company has no reported instances of exceeding emission standards during the reporting period[153]. - The company has implemented strict rain and sewage diversion measures, ensuring that production wastewater is collected and treated[157]. - The company has installed online monitoring devices at wastewater and exhaust emission outlets to ensure compliance with environmental standards[158]. - The company has undertaken measures to reduce carbon emissions, including the recovery of condensate water and the introduction of energy-efficient equipment[167]. Strategic Initiatives - The company plans to enhance environmental protection measures in response to stricter regulations, which may increase operational costs[139]. - The company is committed to monitoring exchange rate fluctuations and exploring financial instruments to mitigate risks associated with currency volatility[140]. - The company is constructing a large industrial park with a total area of 98,858.7 square meters for production, office, and R&D purposes[85]. - The company has established a joint laboratory with Fuzhou University and a "production-study-research" cooperation model with Wuyi University to enhance technology development and talent training[103]. - The company is committed to expanding its market presence through strategic partnerships and product diversification, aiming for sustained growth in the competitive landscape[67]. Corporate Governance - The company has fulfilled all commitments made by actual controllers and shareholders during the reporting period[172]. - There are no instances of non-operating fund occupation by controlling shareholders or related parties during the reporting period[173]. - The company has not engaged in any violations regarding external guarantees during the reporting period[174]. - The semi-annual financial report for the company has not been audited[175]. - The company has not engaged in poverty alleviation or rural revitalization efforts during the reporting period[169]. - There are no significant lawsuits or arbitration matters reported during the period, ensuring no major adverse impact on the company's operations[178]. - The company has not distributed cash dividends or issued new shares from capital reserves during the reporting period, indicating a focus on retaining earnings[147].

Financial Performance - The company's revenue for Q1 2022 was ¥687,223,216.02, a decrease of 19.67% compared to ¥855,515,557.93 in the same period last year[3] - The net profit attributable to shareholders was -¥61,195,748.76, representing a decline of 167.17% from ¥91,100,639.47 year-on-year[3] - The basic earnings per share were -¥0.1185, down 167.18% from ¥0.1764 in the previous year[3] - Operating profit for the quarter was a loss of ¥63,532,710.53, compared to a profit of ¥110,544,769.27 in the same period last year[34] - The company reported a comprehensive loss of -61,181,455.24 CNY for Q1 2022, compared to a comprehensive income of 89,471,105.99 CNY in the previous year[35] - The net profit for Q1 2022 was -60,955,836.68 CNY, compared to a net profit of 90,963,314.64 CNY in Q1 2021, indicating a significant loss swing[35] Cash Flow - The net cash flow from operating activities was ¥97,211,444.26, a decrease of 3.54% compared to ¥100,781,347.63 in the same period last year[3] - The net cash flow from investing activities increased by 198.15% to ¥71,238,728.76, primarily due to the redemption of financial products[17] - The net cash flow from financing activities was ¥116,300,940.80, an increase of 281.49% compared to -¥64,080,973.36 in the previous year[17] - The operating cash flow for Q1 2022 was 97,211,444.26 CNY, slightly down from 100,781,347.63 CNY in Q1 2021[37] - The investment activities generated a net cash inflow of 71,238,728.76 CNY in Q1 2022, a recovery from a net outflow of -72,578,284.66 CNY in the same period last year[38] - The financing activities resulted in a net cash inflow of 116,300,940.80 CNY in Q1 2022, compared to a net outflow of -64,080,973.36 CNY in Q1 2021[38] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,521,474,053.25, a decrease of 1.51% from ¥4,590,769,337.03 at the end of the previous year[5] - Current liabilities totaled ¥1,544,223,232.88, down from ¥1,633,216,341.54, indicating a reduction of 5.4%[32] - Non-current liabilities increased to ¥901,070,317.05 from ¥822,126,163.73, marking an increase of 9.6%[32] - The company's cash and cash equivalents included trading financial assets of ¥10,000,000.00, unchanged from the previous period[30] - The cash and cash equivalents at the end of Q1 2022 totaled 855,820,528.53 CNY, an increase from 478,471,576.38 CNY at the end of Q1 2021[38] Shareholder Information - The total number of common shareholders at the end of the reporting period is 31,694[19] - The largest shareholder, Jian Guangjia Enterprise Management Consulting Service Co., Ltd., holds 9.61% of shares, totaling 49,622,557 shares[19] - The second-largest shareholder, Norsbel (Hong Kong) Nonwoven Products Co., Ltd., holds 9.17% of shares, totaling 47,392,045 shares[19] - The company has a total of 42,678,375 restricted shares, with 2,485,416 shares released during the period[25] - The company has a total of 40,192,959 restricted shares remaining after the recent release[25] - The company has not disclosed any information regarding the relationships or concerted actions among the top shareholders[21] Operational Challenges - The company is facing a mandatory relocation due to environmental regulations, affecting its subsidiary, Fujian Nanping Qingsong Chemical Co., Ltd.[26] - The company is actively communicating with relevant authorities regarding the government planning documents and future operational matters[26] - The company will continue to monitor the situation closely and fulfill its disclosure obligations as required by regulations[26] Expenses - Total operating costs increased to ¥759,024,896.92, up 1.8% from ¥746,692,717.18 in the previous period[34] - The company reported a significant increase in financial expenses by 70.26% to ¥15,330,453.81, attributed to higher average loan balances[14] - Research and development expenses rose to ¥26,556,845.90, an increase of 11.6% compared to ¥23,786,420.13 in the previous period[34] - The company reported a net credit impairment loss of ¥6,859,618.04, compared to a gain of ¥614,801.90 in the previous period[34] Other Information - The company's cash and cash equivalents at the end of the reporting period amount to ¥858,343,954.30, an increase from ¥573,943,250.14 at the beginning of the year[28] - The company did not undergo an audit for the Q1 2022 report[39] - The company experienced a decrease in other comprehensive income, with a tax-adjusted net amount of -225,618.56 CNY in Q1 2022, compared to -1,492,208.65 CNY in the previous year[35]

Financial Performance - The company reported a significant decline in annual performance for 2021, with specific reasons and improvement measures detailed in the management discussion section[4]. - The company plans not to distribute cash dividends, issue bonus shares, or increase capital using reserves[5]. - The company has not disclosed specific financial figures or performance metrics in the provided documents, indicating a need for further detailed financial analysis[4]. - The company's operating revenue for 2021 was approximately ¥3.69 billion, a decrease of 4.44% compared to ¥3.86 billion in 2020[21]. - The net profit attributable to shareholders was a loss of approximately ¥911.67 million, a decline of 297.85% from a profit of ¥460.80 million in 2020[21]. - The net cash flow from operating activities was approximately ¥44.20 million, down 94.52% from ¥805.84 million in 2020[21]. - The total assets at the end of 2021 were approximately ¥4.59 billion, a slight decrease of 0.78% from ¥4.63 billion at the end of 2020[21]. - The net assets attributable to shareholders decreased by 31.87% to approximately ¥2.14 billion from ¥3.13 billion in 2020[21]. - The company reported a basic and diluted earnings per share of -¥1.7648 for 2021, compared to ¥0.8920 in 2020[21]. - The company experienced a significant decline in the weighted average return on equity, dropping to -34.70% from 14.86% in 2020[21]. - In Q4 2021, the company reported a net profit loss of approximately ¥1.03 billion, following a loss of ¥61.98 million in Q3[24]. Market and Industry Trends - The cosmetics market in China reached a consumption scale of approximately ¥402.6 billion in 2021, with a year-on-year growth of 14%[35]. - The import value of beauty and personal care products increased by 23.1% in 2021, indicating intensified competition in the domestic cosmetics market[35]. - The cosmetics industry is experiencing short-term pressure due to the pandemic, but the long-term growth trend remains unchanged[38]. - In 2021, over 886,000 cosmetics-related companies were deregistered, marking an 18% year-on-year increase[40]. - The implementation of the Cosmetics Supervision and Administration Regulations on January 1, 2021, has raised the entry barriers for cosmetics manufacturers[39]. - Rising raw material prices, high shipping costs, and increased labor costs are compressing profit margins for cosmetics manufacturers[38]. - The e-commerce channel continues to grow rapidly, driven by the rise of influencer marketing and live streaming, enhancing consumer awareness of cosmetics[45]. - The long-term outlook for the cosmetics industry is positive, supported by the increasing proportion of young consumers and the ongoing upgrade of high-end brand consumption[38]. - The new regulatory environment is expected to accelerate industry consolidation, benefiting companies with strong R&D and cost control capabilities[40]. Company Operations and Structure - The company operates several wholly-owned subsidiaries, including Nosbel Cosmetics and Guangdong Nosbel Health Care, which may contribute to its overall business strategy[13]. - The company has a dedicated investor relations team to handle inquiries and maintain communication with stakeholders[18]. - The company’s annual report is available on the Shenzhen Stock Exchange website and other financial media platforms[19]. - The company has not reported any changes in its registered address, suggesting stability in its operational location[17]. - The company remains a leading player in the domestic pine oil deep processing industry, with a focus on synthetic camphor and related products[49]. - The cosmetics business is primarily operated by the subsidiary Norsbel, which is one of the largest comprehensive cosmetics manufacturers in China, focusing on ODM services for brand owners[52]. - The company has established a stable procurement network for raw materials, particularly for turpentine, to reduce costs and supply risks[76]. - The company has a strong customer loyalty, built through years of professional expertise and stable partnerships with well-known brands[75]. - The company has established strong partnerships with universities and research institutions to enhance its technology innovation capabilities[96]. Research and Development - The company is committed to continuous innovation and development of competitive products for its clients, enhancing market presence[60]. - Norsbel has a professional R&D team of over 290 people, with 99 patents held as of the reporting period[95]. - The company is developing new cosmetic products using recombinant proteins, which have shown significant efficacy in skin repair during internal testing[147]. - The company has implemented a new high-pressure micro-injection technology for the development of nano-liquid crystal carriers, enhancing product efficacy and stability[147]. - The company is focused on developing innovative cosmetic products with significant whitening effects using electrospun nanofibers[148]. - The company’s R&D investment in 2021 amounted to ¥124,233,355.99, representing 3.36% of total revenue, an increase from 3.20% in 2020[150]. - The company increased its R&D personnel from 336 in 2020 to 369 in 2021, representing a growth of 9.82%[149]. - The proportion of R&D personnel in the company rose from 4.25% in 2020 to 5.44% in 2021, an increase of 1.19%[149]. Financial Challenges and Risks - The company is facing potential risks in future operations, which are elaborated in the management discussion section[4]. - The company reported a goodwill impairment of RMB 913.43 million due to the acquisition of 90% of Norsbel, significantly affecting annual operating performance[198]. - The company faces risks from fluctuating raw material prices, particularly in the cosmetics sector, which could impact profit margins if costs cannot be passed to customers[190]. - The company has established a data analysis team to quickly respond to market trends and consumer changes, utilizing a million-data system for product selection decisions[104]. - The company has a long-term foreign trade operator registration, ensuring compliance with international trade regulations[100]. Production and Manufacturing - The company has a strong manufacturing capability with 43 sets of vacuum emulsification equipment and 55 automatic filling and packaging production lines, enhancing production efficiency[113]. - The company emphasizes quality control, ensuring that each batch of products undergoes rigorous quality inspections before being stored or sold[77]. - The company has completed the expansion project for Norsbel, adding 14 skincare production lines with an annual capacity of 9,470 tons, and 39 wet wipe production lines with an annual capacity of 19.2 billion pieces[86]. - The synthetic camphor expansion project has been completed, with an annual production capacity of 5,000 tons[90]. - The company has implemented a strict quality control system, achieving multiple management system certifications including ISO9001 and ISO14001[111]. Strategic Goals and Future Plans - The company aims to strengthen its market position through product diversification and strategic partnerships in the cosmetics industry[60]. - The company plans to extend its industrial chain and leverage its chemical industry foundation to tap into the vast market potential of the cosmetics sector[176]. - The company aims to drive product innovation through strong R&D capabilities and advanced production processes to create new profit growth points[176]. - The company aims to become an international first-class cosmetics manufacturing service provider, focusing on customer needs and increasing R&D investment for new product development[179]. - The company will strengthen its core technology innovation and increase R&D and technological transformation investments to improve industry competitiveness[184]. - The company will actively explore the cosmetics industry chain through team integration, project investment, and external mergers and acquisitions[185].

Financial Performance - The company's revenue for Q3 2021 was ¥754,184,401.58, a decrease of 21.29% compared to the same period last year[3] - The net profit attributable to shareholders was -¥61,982,999.54, representing a decline of 147.00% year-on-year[3] - The net profit after deducting non-recurring gains and losses was -¥63,498,933.20, down 154.54% from the previous year[3] - Total operating revenue for Q3 2021 was ¥2,664,857,342.42, a decrease of 3.2% compared to ¥2,753,191,063.39 in Q3 2020[24] - Net profit for Q3 2021 was ¥118,474,762.52, down 67.6% from ¥365,567,356.04 in Q3 2020[26] - Earnings per share (EPS) for Q3 2021 was ¥0.2297, compared to ¥0.6928 in Q3 2020[26] Cash Flow - The cash flow from operating activities was -¥119,379,420.37, a decline of 114.96% year-to-date[3] - The net cash flow from operating activities decreased by 114.96% to -119,379,420.37 RMB compared to the same period last year, primarily due to reduced cash receipts from sales and increased procurement costs[13] - The net cash flow from investing activities improved by 80.51%, amounting to -139,069,002.22 RMB, mainly due to a decrease in external investments[13] - The net cash flow from financing activities increased significantly by 202.63% to 267,547,983.85 RMB, primarily due to new bank loans[13] - The total cash and cash equivalents increased by 104.40% to 7,932,387.97 RMB, mainly driven by the new bank loans[13] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,316,848,460.64, an increase of 14.92% compared to the end of the previous year[4] - Total assets increased to ¥5,316,848,460.64, up from ¥4,626,651,433.40 year-over-year[22] - Total liabilities rose to ¥2,150,254,024.22, compared to ¥1,491,524,339.66 in the same period last year[22] - Total current assets reached 2,565,653,653.85 RMB, up from 2,161,521,929.71 RMB, showing a growth of about 18.7%[20] - Fixed assets increased to 681,706,128.51 RMB from 646,768,900.63 RMB, indicating a growth of approximately 5.4%[20] Inventory and Borrowings - Inventory increased by 56.59% to ¥1,170,459,572.22 due to rising procurement costs and delayed shipments from overseas customers[9] - Short-term borrowings rose by 142.59% to ¥419,695,598.18 to supplement working capital[9] - Inventory increased significantly to 1,170,459,572.22 RMB from 747,463,316.61 RMB, reflecting a growth of approximately 56.5%[20] Expenses - The company reported a significant increase in sales expenses, which decreased by 46.82% to ¥44,211,213.42 due to reclassification of transportation costs[11] - Total operating costs increased to ¥2,525,489,079.44, up 7.4% from ¥2,350,036,129.21 in the previous year[25] - Research and development expenses for Q3 2021 were ¥90,192,385.71, slightly up from ¥85,156,321.33 in Q3 2020[25] - The company reported a decrease in sales expenses to ¥44,211,213.42 from ¥83,131,136.03 in the previous year[25] Other Information - The company received government subsidies amounting to ¥4,401,461.50 during the reporting period, contributing to other income[5] - The company has not disclosed any new product developments or market expansion strategies in the current report[16] - The company has not undergone an audit for the third quarter report[39] - Minority interests were recorded at CNY 721,336.32, remaining unchanged from the previous period[38]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥1,910,672,940.84, representing a 6.45% increase compared to ¥1,794,972,434.24 in the same period last year[22]. - The net profit attributable to shareholders of the listed company decreased by 20.08% to ¥180,627,074.82 from ¥226,019,516.29 in the previous year[22]. - The net cash flow from operating activities significantly dropped by 83.81%, amounting to ¥88,246,943.97 compared to ¥545,148,138.24 in the same period last year[22]. - Basic earnings per share decreased by 20.07% to ¥0.3497 from ¥0.4375 in the previous year[22]. - Total assets at the end of the reporting period were ¥4,839,987,755.14, an increase of 4.61% from ¥4,626,651,433.40 at the end of the previous year[22]. - The net assets attributable to shareholders of the listed company increased by 2.90% to ¥3,225,406,227.30 from ¥3,134,405,757.42 at the end of the previous year[22]. - The weighted average return on net assets decreased to 5.63% from 7.33% in the previous year, a decline of 1.70%[22]. - The company reported a total of ¥2,984,257.33 in non-recurring gains and losses during the reporting period[26]. - The company achieved a significant reduction in sales expenses, which decreased by 38.89% to ¥31,271,752.62, due to a reclassification of transportation costs[105]. - The company reported a significant increase in financial expenses by 81.70% to ¥22,702,083.82, mainly due to changes in leasing standards and foreign exchange losses[105]. Business Segments - The company operates primarily in two business segments: cosmetics design, R&D, and manufacturing, and deep processing of turpentine products[30]. - The cosmetics segment is mainly driven by its wholly-owned subsidiary, Norsbel, which focuses on masks, skincare products, and wet wipes[31]. - The cosmetics segment generated operating revenue of CNY 1,254.93 million, up 9.18% year-on-year, but operating profit fell by 52.97%[87]. - The deep processing business of turpentine achieved operating revenue of CNY 655.75 million, a growth of 1.57% year-on-year, with a gross margin of 30.20%, down 2.24%[90]. Market Trends - The skincare market in China saw a 6.58% year-on-year growth in 2020, with skincare products holding a 51.12% market share[34]. - The cosmetics market in China has grown from 204.9 billion RMB in 2015 to 340 billion RMB in 2020, with a compound annual growth rate (CAGR) of approximately 8.81%[68]. - In the first half of 2021, the retail sales of cosmetics in China reached 191.7 billion RMB, representing a year-on-year growth of 26.6%[68]. - The cosmetics industry in China is experiencing a significant increase in consumer spending on personal care, driven by rising income levels and heightened awareness of skincare[74]. - The retail channel for cosmetics has rapidly developed, with a notable increase in online penetration due to the rise of e-commerce platforms[72]. R&D and Innovation - The company has advanced R&D centers and international standard production bases to support its product offerings[36]. - The company’s R&D team consists of over 280 members, and it developed more than 700 new formulas during the reporting period, focusing on various textures, effects, and cost gradients[97]. - The company has established multiple joint R&D centers with universities, including a partnership with Jinan University and Zhejiang University, to enhance innovation in product development[96]. - The company has a total of 77 patents, including 24 invention patents and 42 utility model patents, with 1 new invention patent and 11 utility model patents added during the reporting period[97]. - Norsbel continues to innovate and develop competitive products for its downstream clients, enhancing its market position[42]. Production and Quality Control - The production of high-quality masks, skincare products, and wet wipes is primarily conducted in-house, supplemented by outsourced processes for specific tasks[56]. - The company emphasizes strict procurement management to ensure the quality of raw materials, which significantly impacts the quality of cosmetic products[55]. - The company has established a comprehensive quality control system, certified by multiple international standards, ensuring high product quality throughout the production process[98]. - The company has a strong production capacity with 40 sets of vacuum emulsification equipment and 55 automatic mask filling and packaging production lines, among others[99]. - The company emphasizes production safety and quality control, ensuring that each batch of products meets rigorous inspection standards before being released for sale[62]. Environmental Responsibility - The company is classified as a key pollutant discharge unit by environmental protection authorities[149]. - The wastewater treatment station of Longsheng Fragrance has a daily processing capacity of 1,000 tons, handling approximately 500 tons of wastewater per day during the reporting period[155]. - The company has signed an agreement with Longsheng Fragrance to ensure that the daily wastewater discharge from Qingsong Chemical does not exceed 500 tons, which is processed and discharged after treatment[155]. - The company has implemented strict rainwater and sewage separation measures across its facilities to enhance wastewater management[155]. - The company has established emergency response plans for environmental incidents, ensuring preparedness for hazardous material leaks and other emergencies[163]. Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company is actively investing in R&D to adapt to new regulations in the cosmetics industry, enhancing customer loyalty[87]. - The company plans to adjust its industrial structure and strengthen R&D innovation to maintain stable and high-quality development amid external economic challenges[131]. - The company has developed a multi-channel sales model, achieving certifications in major global markets including the USA, EU, and Japan[63]. - The company has established long-term partnerships with over 30 global raw material suppliers, ensuring stable supply and quality[93]. Risks and Challenges - The company faces potential risks in its future operations, which are detailed in the report[5]. - The company’s cosmetics business is facing increased competition due to the rapid growth of the industry, which may impact its market share and operational performance[134]. - The company’s products are subject to quality control risks, particularly in the cosmetics sector, which could lead to consumer complaints and affect brand reputation[135]. - The company faces goodwill impairment risks related to its acquisition of 90% of Nosber, which could negatively impact future financial performance if market conditions worsen[139]. - The company is actively monitoring raw material price fluctuations, particularly for turpentine, which is critical for its deep processing business[132].

Group 1: Event Details - Fujian Qingsong Co., Ltd. will participate in the "2021 Annual Fujian Listed Companies Investor Online Collective Reception Day" [2] - The event will be held online on May 14, 2021, from 15:30 to 17:00 [2] - Investors can join the event through the "Panjing Network Investor Relations Interactive Platform" [2] Group 2: Participants - Attendees include General Manager Mr. Li Yong, Board Secretary Mr. Luo Qihui, and Chief Financial Officer Mr. Wang Yusong [2] - The company encourages widespread investor participation [2] Group 3: Company Assurance - The company and its board guarantee that the information disclosed is true, accurate, and complete, with no false records or misleading statements [2]

Financial Performance - The company's operating revenue for Q1 2021 was ¥855,515,557.93, representing a 20.69% increase compared to ¥708,867,361.15 in the same period last year[7]. - The net profit attributable to shareholders for Q1 2021 was ¥91,100,639.47, an increase of 8.77% from ¥83,754,720.52 in the previous year[7]. - The basic earnings per share for Q1 2021 was ¥0.1764, up 8.82% from ¥0.1621 in the previous year[7]. - The total operating revenue for Q1 2021 was CNY 855,515,557.93, an increase of 20.7% compared to CNY 708,867,361.15 in the same period last year[53]. - The net profit attributable to shareholders was 91.10 million yuan, an increase of 8.77% compared to the previous year[23]. - The total profit for the quarter was CNY 109,485,928.93, compared to CNY 108,009,025.69 in the same period last year, reflecting a growth of 1.4%[54]. - The total comprehensive income attributable to shareholders of the parent company was CNY 89,632,003.46, compared to CNY 84,214,946.43 in the previous year, indicating a growth of 6.4%[55]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 50.13%, amounting to ¥100,781,347.63 compared to ¥202,075,951.46 in the same period last year[7]. - The net cash flow from operating activities was 100,781,347.63, a decrease of 50.2% compared to 2020's 202,075,951.46[61]. - As of March 31, 2021, the company's cash and cash equivalents decreased to CNY 478.47 million from CNY 514.62 million at the end of 2020, indicating a decline in liquidity[45]. - The cash and cash equivalents at the end of the period were 478,471,576.38, down from 705,610,237.08 in the previous year[62]. - The company reported a decrease in cash inflow from sales of goods and services to 167,711,362.50, down from 226,399,847.26 in the previous year[64]. Assets and Liabilities - Total assets at the end of the reporting period were ¥4,871,790,305.32, a 5.30% increase from ¥4,626,651,433.40 at the end of the previous year[7]. - Current liabilities amounted to CNY 1,078,301,319.73, an increase from CNY 1,012,000,071.99, representing a rise of 6.5%[47]. - Total liabilities increased to CNY 1,644,158,252.27 from CNY 1,491,524,339.66, indicating a growth of 10.2%[47]. - The company's equity attributable to shareholders reached CNY 3,227,071,614.20, up from CNY 3,134,405,757.42, reflecting a growth of 3%[48]. - The total current assets amounted to 2,161,521,929.71, with total assets reaching 4,626,651,433.40[68]. Expenses and Investments - The management expenses rose to 44.89 million yuan, a 30.61% increase due to higher leasing costs and employee salaries[18]. - R&D expenses increased by 38.88% to 23.79 million yuan, reflecting the company's commitment to innovation[18]. - The net cash flow from investing activities was -72.58 million yuan, a 155.57% increase, attributed to investments in long-term assets[20]. - The company incurred a cash outflow of 101,000,000.00 for debt repayment, slightly lower than 106,630,500.00 in the previous year[65]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,787[11]. - The largest shareholder, Ji'an Guangjia Enterprise Management Consulting Service Co., Ltd., held 9.61% of the shares, totaling 49,622,557 shares[11]. - The company did not engage in any repurchase transactions during the reporting period[12]. Risks and Challenges - The company faces significant risks from fluctuations in the price of turpentine, which is a key raw material for its deep processing business, potentially impacting gross margins and overall performance[29]. - The cosmetics industry is experiencing rising raw material prices, with non-woven fabric facing supply shortages, which could affect the company's gross margins if costs cannot be passed on to customers[29]. - The company is exposed to intensified competition in the cosmetics sector due to the rapid growth of the market, which may lead to a loss of major clients if it fails to meet their demands in product formulation and quality control[30]. - The company reported a net foreign exchange loss of CNY 14,500 due to fluctuations in the RMB/USD exchange rate, indicating potential risks from currency volatility in future periods[34]. - The company has a goodwill impairment risk associated with its acquisition of 90% of Nosber, which may negatively impact future earnings if market conditions worsen[35]. Strategic Initiatives - The company established a new R&D center in Hangzhou to enhance product development capabilities[28]. - The company plans to strengthen cost control and improve operational efficiency in response to macroeconomic challenges[28]. - The company plans to enhance its environmental protection investments to comply with stricter national standards, which may increase operational costs[33]. - The company is actively monitoring exchange rate changes and exploring financial tools to mitigate risks associated with currency fluctuations[34].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2020, representing a year-on-year increase of 15% compared to 2019[13] - The net profit attributable to shareholders was RMB 150 million, which is a 10% increase from the previous year[13] - The company's operating revenue for 2020 was ¥3,864,762,214.77, representing a 32.90% increase compared to ¥2,908,117,124.29 in 2019[19] - The net profit attributable to shareholders for 2020 was ¥460,795,675.21, a slight increase of 1.68% from ¥453,164,927.98 in 2019[19] - The net cash flow from operating activities reached ¥805,835,598.05, a 19.17% increase from ¥676,232,559.28 in 2019[19] - The total assets at the end of 2020 were ¥4,626,651,433.40, a decrease of 0.61% from ¥4,655,029,425.44 at the end of 2019[19] - The company's net assets attributable to shareholders increased by 3.51% to ¥3,134,405,757.42 from ¥3,028,018,489.77 in 2019[19] - The company reported a significant focus on product quality, with all batches undergoing rigorous quality inspections before being approved for sale[57] - The company reported a net profit for the period, resulting in retained earnings of ¥1.32 billion, which is 28.55% of total assets, an increase of 8.27% from the previous year[162] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of RMB 1.8 per 10 shares, totaling approximately RMB 93 million[5] - The company distributed a cash dividend of RMB 1.35 per share, totaling RMB 69.74 million, based on a total share capital of 516,580,886 shares, reflecting its commitment to shareholder returns[198] - The company has established a three-year shareholder return plan for 2021-2023, indicating a strategic focus on enhancing shareholder value while balancing operational needs[199] Market Expansion and Strategy - The company is focusing on expanding its market presence in Southeast Asia, targeting a 25% growth in that region for 2021[13] - The company aims for a revenue growth target of 20% for the fiscal year 2021, driven by new product launches and market expansion strategies[13] - The company emphasizes a multi-channel sales strategy, with a focus on both domestic and international markets, ensuring a diversified customer base and reduced concentration risk[58] - The company has established a stable customer base in major global markets, including the US, EU, and Japan, through years of market expansion efforts[58] Product Development and Innovation - New product development includes the launch of a new line of eco-friendly chemical products, expected to contribute an additional RMB 200 million in revenue in 2021[13] - The company has allocated RMB 50 million for research and development in new technologies for sustainable production methods[13] - The company emphasizes innovation and R&D, developing competitive and patented products for downstream partners, enhancing market competitiveness[51] - The company has launched several new skincare products, including the "Natural Hall·Himalaya Elasticity Mask" and "Mascot Hyaluronic Acid Gel Mask," which feature advanced ingredients like collagen and hyaluronic acid for enhanced skin nourishment[52] - The company is developing sustainable cosmetic products, including effective plant extracts and innovative formulations[152] - The company completed the research on the catalyst process for umbrella hydrocarbons, which reduced production energy consumption and costs while significantly improving production efficiency[151] Acquisitions and Mergers - The company completed the acquisition of 90% of Norsbel Cosmetics Co., Ltd. in April 2019, expanding into the cosmetics manufacturing sector[28] - The company acquired 10% of its subsidiary's shares for a total price of RMB 430 million, completing the transaction in June 2020, resulting in 100% ownership[111] - The company transferred 100% equity of Longsheng Fragrance and Qingsong Logistics for a total of RMB 107.36 million, completing the transfer in September 2020[113] Risks and Challenges - The management highlighted potential risks including raw material price fluctuations and regulatory changes, which could impact future performance[5] - The company acknowledges risks from macroeconomic changes and the impact of the COVID-19 pandemic on its operations, committing to adapt its industrial structure accordingly[187] - The company faced significant risks related to raw material procurement, particularly with turpentine, which has experienced substantial price fluctuations due to factors like supply and demand dynamics[189] - The cosmetics industry is witnessing increased competition, with more contract manufacturers entering the market, which could impact the company's market share if it fails to meet customer demands in areas such as product formulation and delivery times[190] Research and Development - The company has a professional R&D team of over 250 people dedicated to new product development, resulting in a total of 59 patents in the cosmetics sector[120] - The company applied for 61 patents in 2020, receiving authorization for 29 patents, including 5 invention patents and 20 utility model patents[147] - Research and development expenses for 2020 amounted to ¥123,766,699.26, reflecting an 18.50% increase compared to the previous year, primarily due to the longer consolidation period of North Bell[146] Production and Capacity - The company expanded its production capacity by acquiring 13 sets of disposable medical mask production lines and 2 sets of KN95 mask production lines during the pandemic[100] - The design capacity for the mask series is 1.965 billion pieces, with a capacity utilization rate of 41.03%[120] - The investment in the synthetic camphor series is nearly complete, with a design capacity of 31,710 tons and a capacity utilization rate of 86%[120] Environmental and Regulatory Compliance - The company has implemented measures to mitigate environmental risks, ensuring compliance with local regulations and maintaining operational standards to avoid penalties[192] - The company’s environmental and safety certifications are valid and have renewal conditions, ensuring ongoing compliance with regulatory standards[122]